The FINANCIAL -- Eli Lilly and Company announced that a Phase III study, published online by European Urology, showed both Cialis and tamsulosin significantly improved scores on the International Prostate Symptom Score, compared to placebo, in men with signs and symptoms suggestive of benign prostatic hyperplasia.

Cialis improved erectile dysfunction in those men who had both signs and symptoms of BPH and ED. According to Eli Lilly and Company, the study also showed that maximum urinary flow rate increased significantly versus placebo with both Cialis and tamsulosin. This is the first international, placebo-controlled study evaluating Cialis in parallel with tamsulosin for signs and symptoms of BPH in the same population.

Cialis for daily use is approved to treat ED, the signs and symptoms of BPH, and ED and the signs and symptoms of BPH in men who have both conditions .

It is important to note that Cialis is not to be taken with medicines called "nitrates" such as isosorbide dinitrate or isosorbide mononitrate which are often prescribed for chest pain; or with recreational drugs called "poppers" like amyl or butyl nitrite, as the combination may cause an unsafe drop in blood pressure; or if allergic to Cialis or Adcirca, or any of its ingredients. Anyone who experiences any symptoms of an allergic reaction, such as rash, hives, swelling of the lips, tongue or throat, or difficulty breathing or swallowing, should call a healthcare provider or get help right away.

Related Stories

• FDA Advisory Committee Finds Data Support Effectiveness of Tafamidis Meglumine
• Pfizer Names Olivier Brandicourt as President and General Manager
• Janssen Healthcare Innovation Announces Discharge Decision Support System Winner